← Leaderboards
Asok Antony
Indiana Univ-Purdue Univ At Indianapolis
$3,245,063
Attributed
$3,245,063
Total exposure
6
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $287.9K · FY2007–23$500K$375K$250K$125K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$3,245,063 · 4
VA$0 · 2
By mechanism
R01$3,233,063 · 3
R13$12,000 · 1
I01$0 · 2
Top collaborators
No co-investigators on record.
Most similar at Indiana Univ-Purdue Univ At Indianapolis
Same institution · by research overlap
- Ann Roman$3,698,808
Others in their field
Top investigators on “Folate”
- Paul M. Ridker · Brigham And Women'S Hospital$55,416,022
- Brian E Henderson · University Of Southern California$20,353,887
- Ulrike Peters · Fred Hutchinson Cancer Research Center$18,907,654
- James F Toole · Wake Forest University Health Sciences$17,951,480
- John Anthony Baron · Dartmouth College$17,250,532
- Loic Le Marchand · University Of Hawaii At Manoa$17,180,480
Research focus
FolateHuman PapillomavirusHeterogeneous-Nuclear RibonucleoproteinsL2 Viral Capsid ProteinCellsMalignant NeoplasmsFolic Acid DeficiencyTissuesViralCapsid ProteinsAffinityGenerationsKeratinocyteProteinsNuclearParticleElementsPreventDietHela CellsMinorApoptosisGenesFeeding
Grant awards (23)
Characterization of an anti-Human Papillomavirus (HPV) agent$0
I01 · FY2023 · VA · contact PI
Characterization of an anti-Human Papillomavirus (HPV) agent$0
I01 · FY2022 · VA · contact PI
Characterization of an anti-Human Papillomavirus (HPV) agent$0
I01 · FY2021 · VA · contact PI
Characterization of an anti-Human Papillomavirus (HPV) agent$0
I01 · FY2020 · VA · contact PI
Mechanism of Folate Deficiency as a Co-Factor for HPV16-induced Carcinogenesis$0
I01 · FY2016 · VA · contact PI
Mechanism of Folate Deficiency as a Co-Factor for HPV16-induced Carcinogenesis$0
I01 · FY2015 · VA · contact PI
Mechanism of Folate Deficiency as a Co-Factor for HPV16-induced Carcinogenesis$0
I01 · FY2014 · VA · contact PI
Optimizing Maternal-Child Health in Kenya$6,000
R13 · FY2013 · HD · contact PI
Mechanism of Folate Deficiency as a Co-Factor for HPV16-induced Carcinogenesis$0
I01 · FY2013 · VA · contact PI
Optimizing Maternal-Child Health in Kenya$6,000
R13 · FY2012 · HD · contact PI
Nutritional Regulation of hnRNP-E1 and Related Genes$278,293
R01 · FY2011 · CA · contact PI
Nutritional Regulation of hnRNP-E1 and Related Genes$286,900
R01 · FY2010 · CA · contact PI
Nutritional Regulation of hnRNP-E1 and Related Genes$286,900
R01 · FY2009 · CA · contact PI
Nutritional Regulation of hnRNP-E1 and Related Genes$286,979
R01 · FY2008 · CA · contact PI
Nutritional Regulation of hnRNP-E1 and Related Genes$287,850
R01 · FY2007 · CA · contact PI
FOLATE-RESPONSIVE DYSGENESIS$234,675
R01 · FY2004 · HD
FOLATE-RESPONSIVE DYSGENESIS$234,675
R01 · FY2003 · HD
FOLATE-RESPONSIVE DYSGENESIS$234,675
R01 · FY2002 · HD
EXPERIMENTAL THERAPEUTICS EXPLOITING FOLATE RECEPTORS$201,150
R01 · FY2002 · CA
FOLATE-RESPONSIVE DYSGENESIS$234,675
R01 · FY2001 · HD
EXPERIMENTAL THERAPEUTICS EXPLOITING FOLATE RECEPTORS$201,150
R01 · FY2001 · CA
FOLATE-RESPONSIVE DYSGENESIS$263,878
R01 · FY2000 · HD
EXPERIMENTAL THERAPEUTICS EXPLOITING FOLATE RECEPTORS$201,263
R01 · FY2000 · CA